Oropharynx cancer
MONDO:0004608A primary or metastatic malignant neoplasm that affects the oropharynx.
Also known as: cancer of oropharynx, malignant neoplasm of junctional region of oropharynx, malignant neoplasm of lateral wall of oropharynx, malignant neoplasm of oropharynx, malignant neoplasm of posterior wall of oropharynx, malignant neoplasm of the oropharynx, malignant oropharyngeal neoplasm, malignant oropharyngeal tumor
3220 clinical trials for this condition and its sub-types, 150 tagged with Oropharynx cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Oropharynx cancer
-
Oropharyngeal carcinoma 100 trials · 243 incl. sub-types
6 sub-types
- Oropharynx squamous cell carcinoma 192 trials · 195 incl. sub-types Sub-types →
- Tonsil carcinoma 1 trial · 5 incl. sub-types Sub-types →
- Carcinoma in situ of oropharynx 1 trial Sub-types →
- Carcinoma of soft palate 1 trial
- Adenoid cystic carcinoma of oropharynx 0 trials
- Epiglottis cancer 0 trials Sub-types →
-
Waldeyer's ring cancer 0 trials · 8 incl. sub-types
1 sub-type
- Tonsil cancer 5 trials · 8 incl. sub-types Sub-types →
-
Soft palate cancer 0 trials · 1 incl. sub-types
2 sub-types
- Carcinoma of soft palate 1 trial
- Uvula cancer 0 trials
-
Vallecula cancer 0 trials
Most studied deeper sub-types
-
Promising combo for HPV throat cancer hits snag: trial stopped early
Disease control Stopped earlyThis study looked at adding two immunotherapy drugs (ipilimumab and nivolumab) to standard radiation for people with advanced HPV-positive throat cancer. The goal was to see if the combination was safe and could shrink tumors better than radiation alone. The trial enrolled 37 par…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Experimental immune drug tested in HPV cancers – but trial halted early
Knowledge-focused Stopped earlyThis very early trial tested a single dose of HB-201 in 10 people with HPV 16+ throat or cervical cancer. The goal was to see how the drug affects the immune system, not to treat the cancer. The study was terminated early, so results are limited.
Early phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Study probes why patients delay throat cancer diagnosis
Knowledge-focused Stopped earlyThis study looked at why people with mouth or throat cancer wait before seeing a doctor. Researchers interviewed 90 patients and asked them to fill out questionnaires about their feelings, thoughts, and social situation. The goal was to understand what factors cause the delay, so…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC